DE69916287D1 - Verfahren zur synthese von carbapenem-zwischenprodukten - Google Patents

Verfahren zur synthese von carbapenem-zwischenprodukten

Info

Publication number
DE69916287D1
DE69916287D1 DE69916287T DE69916287T DE69916287D1 DE 69916287 D1 DE69916287 D1 DE 69916287D1 DE 69916287 T DE69916287 T DE 69916287T DE 69916287 T DE69916287 T DE 69916287T DE 69916287 D1 DE69916287 D1 DE 69916287D1
Authority
DE
Germany
Prior art keywords
alkyl
formula
carbapenem
compound
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69916287T
Other languages
English (en)
Other versions
DE69916287T2 (de
Inventor
R Humphrey
A Miller
Nobuyoshi Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE69916287D1 publication Critical patent/DE69916287D1/de
Application granted granted Critical
Publication of DE69916287T2 publication Critical patent/DE69916287T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69916287T 1998-06-17 1999-06-11 Verfahren zur synthese von carbapenem-zwischenprodukten Expired - Fee Related DE69916287T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8958598P 1998-06-17 1998-06-17
US89585P 1998-06-17
PCT/US1999/013263 WO1999065921A1 (en) 1998-06-17 1999-06-11 Process for the synthesis of carbapenem intermediates, and compounds produced

Publications (2)

Publication Number Publication Date
DE69916287D1 true DE69916287D1 (de) 2004-05-13
DE69916287T2 DE69916287T2 (de) 2005-03-24

Family

ID=22218455

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69916287T Expired - Fee Related DE69916287T2 (de) 1998-06-17 1999-06-11 Verfahren zur synthese von carbapenem-zwischenprodukten

Country Status (9)

Country Link
US (1) US6489471B1 (de)
EP (1) EP1104424B1 (de)
JP (1) JP2002518402A (de)
AT (1) ATE263766T1 (de)
AU (1) AU744644B2 (de)
CA (1) CA2334820C (de)
DE (1) DE69916287T2 (de)
ES (1) ES2217768T3 (de)
WO (1) WO1999065921A1 (de)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309438A (en) 1977-05-05 1982-01-05 Merck & Co., Inc. N-Alkyl-N-iminomethyl derivatives of thienamycin
US4994568A (en) 1980-12-18 1991-02-19 Merck & Co., Inc. 6- and 4-substituted-1-azabicyclo(3.2.0)heptan-3, 7-dione-2-carboxylates
US4479947A (en) 1981-07-13 1984-10-30 Merck & Co., Inc. Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group
KR900006449B1 (ko) 1982-08-24 1990-08-31 상꾜 가부시끼가이샤 아제티디논 화합물의 제조방법
GB8520631D0 (en) 1985-08-16 1985-09-25 Hoechst Uk Ltd Derivatives
JP2687347B2 (ja) * 1987-04-22 1997-12-08 東ソー株式会社 芳香族ホスフィンおよびそれを用いる分析法
GB8804058D0 (en) 1988-02-22 1988-03-23 Fujisawa Pharmaceutical Co 3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds
JPH03120280A (ja) 1989-10-03 1991-05-22 Shionogi & Co Ltd ハロメチルカルバペネム化合物の製法
US5034384A (en) 1990-08-01 1991-07-23 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem antibacterial agents
IL99513A0 (en) 1990-09-20 1992-08-18 Hoechst Ag Process for the preparation of carbapenem compounds
GB9202298D0 (en) 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
EP0695753A1 (de) 1994-08-05 1996-02-07 Zeneca Limited Carbapenem-Derivate mit einem bicyclischen Substituenten, Verfahren zu ihrer Herstellung und ihre Verwendung
CA2189995C (en) 1995-03-10 2001-01-23 Kazuhiro Aihara Novel carbapenem derivatives
US5756725A (en) 1996-04-24 1998-05-26 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
CA2252402C (en) * 1996-04-24 2002-12-24 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
WO1999052908A1 (en) 1998-04-16 1999-10-21 Merck & Co., Inc. Titanium catalyzed preparation of carbapenem intermediates

Also Published As

Publication number Publication date
CA2334820A1 (en) 1999-12-23
EP1104424A4 (de) 2002-01-23
WO1999065921A1 (en) 1999-12-23
US6489471B1 (en) 2002-12-03
AU744644B2 (en) 2002-02-28
DE69916287T2 (de) 2005-03-24
ATE263766T1 (de) 2004-04-15
ES2217768T3 (es) 2004-11-01
EP1104424A1 (de) 2001-06-06
JP2002518402A (ja) 2002-06-25
EP1104424B1 (de) 2004-04-07
CA2334820C (en) 2007-01-23
AU4562899A (en) 2000-01-05

Similar Documents

Publication Publication Date Title
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
DE69106977D1 (de) Verfahren zur Herstellung von Nitrilen.
ATE264268T1 (de) Verfahren zur herstellung von zsm-5 und zsm-11
ATE277999T1 (de) Verfahren zur herstellung von amin- umsetzungsprodukt-teilchen
ATE190972T1 (de) Verfahren zur herstellung von antimikrobiellen verbindungen
DE69328962D1 (de) Verfahren zur herstellng von cyano-methoxyiminomethylderivaten
ATE210136T1 (de) Verfahren zur herstellung von alkylhydrogenchlorsilanen
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
ATE254127T1 (de) Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese
ATE261944T1 (de) Verfahren zur herstellung von carbamoylsubstituierten imidazolderivaten
DE69632919D1 (de) Verfahren zur herstellung von 2-chlor-5-chloromethyl-thiazol
ATE245147T1 (de) Substituierte aminochinazolinon (thion) derivate
ATE263766T1 (de) Verfahren zur synthese von carbapenem- zwischenprodukten
DE69505183D1 (de) Verfahren zur Herstellung von 4-halo-2'nitrobutyrophenon
DE69630184D1 (de) Verfahren zur Herstellung von 1-substituierten Pyrrol-3-carbonsäure-Derivaten
DE59803194D1 (de) Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen
ATE159517T1 (de) Verfahren zur herstellung von n-carbonylarylimine als zwischenprodukte in der synthese von therapeutisch aktiven taxol-derivaten
ATE213493T1 (de) Verfahren zur herstellung von methoximinophenylglyoxylsäure-derivaten
DE69202564D1 (de) Verfahren zur Herstellung von 1,3-Dioxan-4,6-Dionderivaten.
ATE236132T1 (de) Verfahren zur herstellung von 1,3-diaza- spiro(4.4)non-1-en-4-on derivaten und 1-cyano-1- acylaminocyclopentan zwischenprodukte
ATE177737T1 (de) Verfahren zur herstellung von 5-arylhydantoin
ATE123028T1 (de) Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen.
ATE194840T1 (de) Verfahren zur herstellung von antifolaten 4- hydroxypyrrolo 2,3-d pyrimidinderivaten
ATE242211T1 (de) Verfahren zur synthese von 4-substituierten azetidinon-derivaten
ATE244228T1 (de) Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee